tirzepatide as compared with semaglutide for the treatment of obesity on ingestive behavior in adults overweight or obesity: a randomized 6-week phase 1 trial Semaglutide vs. Tirzepatide for Obesity

This suggests both a weight loss-independent effect of tirzepatide, mediated by GIP and GLP-1 receptor agonism as demonstrated by an increase in pancreatic beta-cell glucose sensitivity and enhancing insulin secretion, and other weight loss-dependent effects such as waist circumference

However, most people tolerate it well after slow dose escalation

These visits provide opportunities to assess whether your current dose remains appropriate, evaluate for any emerging safety concerns, and reinforce lifestyle modifications that complement pharmacotherapy

A qualified provider can order genetic or biomarker testing to evaluate your oxidative stress pathways before recommending glutathione dosing or route